Semi-Annual Consolidated Statement Of Comprehensive Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7721845

Concept 2018-04-01 to
2018-06-30
2017-04-01 to
2017-06-30
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,077,000,000 JPY
2,393,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-824,000,000 JPY
846,000,000 JPY
Foreign currency translation adjustment
-79,000,000 JPY
-49,000,000 JPY
Remeasurements of defined benefit plans, net of tax
132,000,000 JPY
158,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
2,000,000 JPY
2,000,000 JPY
Other comprehensive income
-769,000,000 JPY
958,000,000 JPY
Comprehensive income
307,000,000 JPY
3,351,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
307,000,000 JPY
3,351,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.